Error message

The page you requested does not exist. For your convenience, a search was performed using the query events thu 09 jan 1000 systemic anticancer therapy these talks are aimed masters first year phd.

Search results

  1. Dr Catherine Lindon

    ... role of substrate proteolysis in the precisely coordinated events giving rise to two daughter cells at the end of mitosis. The Aurora ...

  2. Dr Athena Matakidou

    ... modify the mouse renal apithelium and replicate the genetic events observed in human renal cell carcinoma. The development of reproducible ...

  3. Dr Mariann Bienz

    ... cell compartment. Our aim is to understand the molecular events underlying Wnt signal transduction. We focus on positively-acting ...

  4. Dr Dario Bressan

    ... for the spatial and temporal control of biological events in vivo. Specifically, I am using photochemically caged ligands and ...

  5. Dr Frank McCaughan

    My research is focused on understanding the early driver events that are critical to the development of squamous lung cancer (SQC) and ...

  6. Professor Gillian Murphy

    ... by trafficking which allows specific localisation in events such as cell invasion. The identification of the importance of specific ...

  7. Dr James Nathan

    Cellular mechanisms of oxygen and metabolite sensing: ...

  8. Dr James Rudd

    ... arteries as a predictor of plaque rupture and clinical events. Additionally, I use non-invasive imaging methods such as PET, MRI and ...

  9. Ms Paola Marco

    ... The inhibitor can be washed out, allowing us to study events in a more flexible way. I will introduce these mutants in RPE cells to ...

  10. Dr Marisa Segal

    ... morphogenesis in S. cerevisiae we have focused on the events that determine SPB asymmetry or spindle polarity, i.e. the mechanisms ...

  11. Dr David Gilligan

    David Gilligan is a Consultant Clinical Oncologist at Addenbrooke's and Papworth Hospitals in Cambridge. He is the Clinical Lead for Acute Oncology at Addenbrooke's. He trained in pre clinical medicine at the University of Edinburgh and clinical...

  12. Mr David Thurtle

    Radiological assessment of prostatic osseous metastases. Robotic-assisted laparoscopic prostatectomy. Early detection of prostate cancer. Risk Prediction in prostate cancer

  13. Professor David Glover

    Our laboratory studies the regulation of progression through mitosis and meiosis in animal cells. The high degree of evolutionary conservation of these regulatory mechanisms means that findings in model organisms are readily applicable to human cells....

  14. Dr Roisin Owens

    Our group works on integrating biological models with electronic devices to generate systems that can be predictive of real biological systems, for drug discovery and therapeutics. We combine expertise in a wide range of disciplines including...

  15. Mr Thierry Lefebvre

    Radiotherapy is often prescribed in oncology clinics to treat solid tumours and to limit the development and the propagation of cancer cells. The lack of oxygenation seen in some tumour regions under chaotic and unrestricted cellular growth constitute a...

  16. Professor Walid Khaled

    My laboratory works on defining the early cellular and molecular events that drive tumour initiation and development. In particular, we focus on how the cell of origin affects the differentiation trajectory of nascent tumour cells and dictates changes...

  17. Dr Andrej Alendar

    RNA methyltransferases

  18. Mr Alexander Evtushenko

  19. Dr Andrew King

  20. Dr Anna Piskorz

    I’m a molecular biologist focus on translational research in high grade serous ovarian cancer (HGSOC). I work on identification of genomic biomarkers that could be applied in clinic as diagnostic, prognostic and predictive biomarkers, helping in better...

  21. Dr Basma Greef

    Supervisor Prof Margaret Ashcroft. Disruption of hypoxia response pathways in renal cancer and how these can be harnessed to develop new treatments. My other interests include clinical trials and the effective management of toxicities related to widely...

  22. Dr Cedric Ghevaert

    Cedric Gevaert graduated from the medical school of the University Libre de Bruxelles in 1997 and subsequently became a fellow of the Royal College of Physicians, London (2000). He specialised in Haematology and became a fellow of the Royal College of...

  23. Dr Christian Dillon

  24. Dr Joanna Baxter

    The Cambridge Blood and Stem Cell Biobank is a facility of over 6000 viable and nucleic acid samples, the majority from patients with haematological malignancy and clonal blood cell disorders; and the remainder, around 20%, from normal individuals,...

  25. Miss Ee June Chua

  26. Dr Elham Shirazi

  27. Dr Alejandra Bruna

    We aimed to study the effects of the TGF-beta pathway in breast cancer stem cell (BCSC) regulation. To define a role of the TGF-beta pathway in the regulation of human BCSCs, we have analyzed a panel of breast cancer cell lines that represent the...

  28. Dr Danish Mazhar

    Dr Mazhar was a Medical Undergraduate at the University of Oxford and completed his Clinical Training in London. He undertook Specialist Training in Medical Oncology at the Hammersmith and Charing Cross Hospitals in London. He was awarded a PhD by...

  29. Mr Giuseppe Aresu

    Mr Aresu is a Consultant Thoracic Surgeon at the Royal Papworth Hospital. He undertook his Cardiothoracic specialist training in Padua, Udine (Italy) and in Bristol (UK). In November 2011 he started working as consultant thoracic surgeon in Udine where...

  30. Mrs Jane Bushen

  31. Mrs Jane Lichfield

  32. Dr Jane Dobson

    As a Veterinary Oncologist, I am interested in many aspects of cancer including diagnostic methods and treatment of commonly occuring cancers in animals eg lymphoma and osteosarcoma. Animals cancer patients could provide an excellent model for...

  33. Dr Janet Maguire

  34. Dr Jan Czarnecki

  35. Dr Ljiljana Fruk

  36. Professor Tony Green

    Tony Green is Professor of Haemato-oncology in the University of Cambridge and honorary Consultant Haematologist at Addenbrookes Hospital. He was appointed Head of the University Department of Haematology (2000-2020), and in 2016 was appointed Director...

  37. Professor David Rubinsztein

  38. Professor Eamonn Maher

    Eamonn Maher is Professor of Medical Genetics and Genomic Medicine and Head of the Department of Medical Genetics. Prior to taking up this post in 2013 he was Professor of Medical Genetics and Academic Lead for the Centre for Rare Diseases and...

  39. Professor Ferdia Gallagher

    Dr Ferdia Gallagher studied medicine as an undergraduate at the University of Cambridge before completing his clinical studies at the University of Oxford. He trained as a radiologist at Addenbrooke?s Hospital in Cambridge. In 2005, he was awarded a...

  40. Dr Helen Davies

  41. Dr Kerstin Meyer

    Genetic Susceptibility to Breast Cancer 1. Functional analysis of predisposition loci: My experiments are aimed at understanding the mechanisms by which breast cancer risk loci contribute to disease risk. This has involved the identification of...

  42. Professor Matthew Allen

    My laboratory is interested in preclinical modelling of musculoskeletal cancer, with a particular emphasis on paediatric cancers (such as osteosarcoma, rhabdomyosarcoma and Ewings sarcoma) and adult cancers that spread to bone (such as breast, prostate,...

  43. Professor Steven Ley

  44. Dr Paul Lyons

    ... to the clinical management of autoimmune diseases such as systemic lupus erythematosus and small vessel vasculitis. This approach will ...

  45. Professor Randall Johnson

    ... homeostasis, including pulmonary vascular tension and even systemic blood pressure.  We have found that this control is highly related to ...

  46. Dr Trevor Littlewood

    The use of classical, germ-line genetics to define gene function in vertebrates is severely limited by embryonic lethality, developmental compensation and adaptive functional degeneracy, all of which obscure the roles played by genes in adult tissues...

  47. Dr Will Ince

    ... prostate and recurrent/metastatic head and neck cancer with systemic treatments  Improving approaches to personalised radiotherapy in ...

  48. Dr Bristi Basu

    ... or show potential as early predictors for efficacy of anticancer drugs. ...

  49. Professor Ian Paterson

    Organic synthesis - generally related to anticancer natural products and analogues. Synthesis of potent cytotoxic ...

  50. Dr Jon Houseley

    ... across the landscape to malignant cells facing targeted anticancer drugs, adaptation is required for survival. We question how new ...

  51. Dr Richard Baird

    ... funded by:  - Cancer Research UK  - EU HORIZON 2020 - AntiCancer Fund - AstraZeneca  - Boehringer-Ingelheim - Genentech - ...

  52. Dr Andrew Gee

    Since 1995, I have been working on technical aspects of clinical ultrasonic imaging, with particular emphasis on three-dimensional imaging and elastography (stiffness imaging). Along with Richard Prager and Graham Treece, I lead the Medical Imaging...

  53. Dr Andre Neves

    ... cancer diagnosis and for better assessing response to cancer therapy. Currently, I'm planning a first-in-human clinical trial of a novel ...

  54. Dr Richard Benson

    Interests based around improving radiotherapy and chemoradiotherapy in head and neck and urological cancers, develpoing technical radiotherapy and evaluating treatment related toxicity.

  55. Professor Bertie Gottgens

    ... blood stem/progenitor cell populations used in cell and gene therapy protocols. ...

  56. Professor Kevin Brindle

    ... techniques to detect the early responses of tumours to therapy, with a view to translating these into clinical application. This has ...

  57. Dr Camilo Colaco

    Developing cancer therapy as opposed to research. Autologous tumour-dendritic cell fusion hybrids ...

  58. Dr Camilo Colaco

  59. Dr Chiwen Chang

    1. Interaction between NK cells and HLA Class I antigen during immune response. 2. Immunotherapy for cancers and autoimmune diseases.

  60. Dr Christopher Jones

    My research focuses on improving the radiation response and post-radiation monitoring of oesophageal cancers, with a particular focus on oesophageal adenocarcinoma. I am also interested in the study of radiotherapy-related genomic evolution.

  61. Dr Claire Connell

    Pancreatic cancer and immunotherapy

  62. Dr Ahsan MEMON

    ... cell behaviours through cell signaling. Ever since, these findings have directly led to expanding and redefining understanding of ... modulator to generate multi-depth multi-chromatic holograms. These holograms are produced through a custom-developed iterative code with ...

  63. Dr Adrian Ionescu

    ... up a strong track record with international recognition in these research areas, with 50 publications and two books to date. With some of these publications I have helped shape the new interdisciplinary field of ...

  64. Professor Andrew Flewitt

    ... thin film piezoelectrics. There are two applications of these. Surface acoustic wave (SAW) devices can be used to make microfluidic ...

  65. Dr Alasdair Russell

    ... model systems in a pre-clinical setting. Further, we use these novel models in a range of pre-clinical trials to advance our ...

  66. Mr Angelos Kolias

    ... and evaluation of PET-guided surgery for pituitary adenomas. These are collaborative projects with Mr Richard Mannion (Clinical Lead for ...

  67. Professor Anna Philpott

    ... a disease of differentiation. Ultimately, our studies on these fundamental mechanisms that co-ordinate proliferation and differentiation ...

  68. Professor Anthony Davenport

    ... imaging using positron emission tomography, to determine how these are altered with disease. Major interests are the role of endothelin-1 in ...

  69. Dr Alex Cagan

    ... our own bodies are constantly acquiring mutations. Some of these mutations may influence cellular phenotypes, such as growth, resulting in ... Over time our bodies become a patchwork of clones. These processes drive cancer progression and may contribute to ageing.  Due to ...

  70. Professor Ben Simons

    ... epidermal maintenance in mouse. Currently, we are extending these ideas to explore cell fate in human epidermis addressing both normal and malignant tissue. These investigations are pursued in close collaboration with experimentalists ...

  71. Dr Andreas Bender

    ... to the prediction of adverse drug reactions. In case you are generating large amounts of chemical or biological data related to cancer drug discovery you are very welcome to contact me to see in which way I could contribute to your ...

  72. Professor Antonis Antoniou

    ... and the development of risk prediction tools which are used in clinical practice. I have a research group of 10 which focuses on ...

  73. Professor Adrian Liston

    We are focussed on understanding the biology of regulatory T cells within the ...

  74. Dr Ashray Gunjur

    I am an early-career medical oncologist from Melbourne, Australia. I am broadly interested in immuno-oncology and the link between cancer and the gut microbiome, and am undertaking a PhD supervised by Dr David Adams and Dr Trevor Lawley (Wellcome...

  75. Miss Amara Cañizares

  76. Dr Fazlur Rahman Talukdar

    ... (IARC-WHO), France, in 2015. During this tenure, my research aimed to identify DNA methylome alterations linked to esophageal cancer within ...

  77. Dr Misha Kapushesky

    ... a universal ecosystem for bioinformatics development, aimed to reduce the chaotic clutter of inefficiency and incompatibility in ...

  78. Dr Nicholas Walton

    ... currently aiding in their search for new techniques aimed at the treatment of breast cancer. ...

  79. Professor Rahul Roychoudhuri

    ... providing targets for development of new therapies aimed at reversing dysfunctional immune responses in cancer. ...

  80. Dr Sujath Abbas

    ... I developed a cost-effective DNA sequencing method (mutREAD) aimed for screening of mutational signatures using FFPE DNA, envisioning its ...

  81. Mr liam masterson

  82. Professor Vincent Gnanapragasam

    ... Cambridge University Hospitals and ARU to establish a Masters in Urology programme for early stage clinicians aspiring to a career in ...

  83. Professor Tim Eisen

    ... where I am currently responsible for oncology trials from first in man to Phase II. ...

  84. Dr Elisa Laurenti

    ... As perturbation of HSC regulatory networks drives the first steps of leukaemia, knowledge of HSC specific molecular responses will ...

  85. Dr Kelly Holmes

    ... CRUK Cambridge Centre Imaging Programme Manager. Kelly has a first class degree in Biochemistry with a year in industry. She completed her ...

  86. Professor Duncan Jodrell

    ... therapies and novel therapeutic combinations, including first into man (phase I) and associated studies.  My research goal is to ...

  87. Dr Laura Blackburn

    ... research and held a workshop on the implementation of the first ctDNA testing services in the NHS, which were facilitating treatment ...

  88. Dr Lori Passmore

    ... of translation to control gene expression, and is the first step in mRNA turnover. The major deadenylase activities are found within ...

  89. Dr Aisling Redmond

    Aisling received her undergraduate degree in Genetics from Trinity College Dublin and PhD from Dublin City University. She completed postdoctoral fellowships in the breast cancer field at the Royal College of Surgeons in Ireland and Cancer Research UK...

  90. Dr David Adams

    ... data for over 200 genetically modified mouse lines per year to gain a better understanding of mammalian gene function. ...

  91. Dr Daniel Hodson

    Pathogenesis of Germinal Centre Derived B Cell Lymphomas. Many of the commonest human lymphomas (including follicular, diffuse large B cell and Burkitt lymphomas) develop from a specific stage of B lymphocyte differentiation termed the Germinal Centre. ...

  92. Mrs Eva Serrao

    Despite medical advances, pancreatic cancer still has a 5-year survival rate of less than 6%. The ideal way to improve this is to ...

  93. Dr Hayley Woffendin

    After many years working as a postdoctoral research scientist (Molecular Biologist) within the University and Wellcome Trust Sanger Institute, I have been Scientific Administrator and Graduate Student Administrator with the Department of Oncology Since...

  94. Dr Hannah Harrison

    Since moving into public health research around 5 years, Hannah has been involved in projects investigating risk-stratification for kidney cancer screening and follow-up. Her most rencet project, funded by CRUK, is investigating multifactorial models...

  95. Dr Adrien Hallou

    ... approaches of biological systems during my MPhil and PhD in Biophysics at the University of Cambridge. I am now a Research Fellow at ...

  96. Dr Amos Burke

    ... and currently co-supervises a Clinical and a basic science PhD student. At a national level Dr Burke is the National Institute for Health ...

  97. Miss Annalisa Occhipinti

    I am a Mathematician and I am doing a PhD in bioinformatics at the University if Cambridge. I am currently working on ...

  98. Ms Ceilidh Welsh

    I am a PhD student working with  Cancer Research UK RadNet Cambridge Radiation ...

  99. Dr Emmanuel Huguet

    ... undergraduate medical students. He subsequently undertook a PhD in cancer molecular biology at Oxford University in the laboratories of the ...

Pages